The field of endocrinology was revolutionized with the advent of the radioimmunoassay (RIA) by Mount Sinai faculty members Rosalyn Yalow, PhD, and Solomon Berson, MD. Dr. Yalow accepted the Nobel Prize for their work in 1977, five years after Dr. Berson’s death.
While not the first important advance in the field at Mount Sinai — the first clinic in New York and the second in the nation for diseases of metabolism were established here – the development of the RIA radically changed research in a way few discoveries can.
Today, our faculty live up to this legacy, conducting basic, clinical, and translational research with a constant focus on how their work can improve the lives of our patients.
Mount Sinai is considered to be a leader in the field of diabetes treatment with the combined strengths of the Mount Sinai Diabetes Center, the Friedman Diabetes Center at Mount Sinai Beth Israel and the clinical abilities of the physicians at Mount Sinai St. Luke’s and Mount Sinai west. Our doctors treat some of the poorest communities in America, East Harlem, Morningside Heights, the Lower East Side, where diabetes rates are among the highest in the nation. Our goal is to provide comprehensive outpatient and inpatient care, conduct research, and educate the local community about disease prevention.
Patients with complicated conditions related to other endocrine glands, including the thyroid, bone and pituitary, are frequently referred to our physicians from throughout the New York area and around the world.
Many of our faculty members are members of the Mount Sinai Diabetes, Obesity and Metabolism Institute. This institute, directed by Andrew Stewart, MD, was created in response to urgent and chronic health care needs of people with diabetes and obesity and the desire to fast track research to bring innovations directly to our patient population. Our faculty are developing collaborations with public health experts, pediatricians, geriatricians, psychiatrists, surgeons, and others to develop new paradigms to address the obesity epidemic.
Our fellowship program provides an in-depth understanding of a range of endocrine and metabolic disorders for eight fellows. We are among the largest and best rated Endocrine training program in the region. We received a full five-year accreditation from the Accreditation Council for Graduate Medical Education in 2015, with the highest review score among all reviewed programs.
Whether you are a current or prospective faculty member, trainee, supporter or patient, our division can provide you with amazing opportunities and advantages. I encourage you to explore our website and learn about our division.
Andrea Dunaif, MD
Professor of Medicine, Endocrinology, Diabetes and Bone Disease
Chief of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease